Search by Drug Name or NDC
NDC 68382-0911-01 Doxycycline 200 mg/20mL Details
Doxycycline 200 mg/20mL
Doxycycline is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is DOXYCYCLINE HYCLATE.
MedlinePlus Drug Summary
Doxycycline injection is used to treat or prevent bacterial infections, including pneumonia and other respiratory tract infections. It is also used to treat certain skin, genital, intestine, and urinary system infections. Doxycycline injection may be used to treat or prevent anthrax (a serious infection that may be spread on purpose as part of a bioterror attack) in people who may have been exposed to anthrax in the air. Doxycycline injection is in a class of medications called tetracycline antibiotics. It works by killing bacteria that cause infections. Antibiotics such as doxycycline injection will not work for colds, flu, or other viral infections. Taking or using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 68382-0911-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Doxycycline Injection
Product Information
| NDC | 68382-0911 |
|---|---|
| Product ID | 68382-911_c89e4254-ee90-4bcc-8f75-ecac716a8f1b |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Doxycycline |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Doxycycline |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/20mL |
| Substance Name | DOXYCYCLINE HYCLATE |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Tetracycline-class Drug [EPC], Tetracyclines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207757 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68382-0911-01 (68382091101)
| NDC Package Code | 68382-911-01 |
|---|---|
| Billing NDC | 68382091101 |
| Package | 1 VIAL in 1 CARTON (68382-911-01) / 20 mL in 1 VIAL |
| Marketing Start Date | 2018-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |